Imexpharm Corporation announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced total revenue was VND 296,437.000 million compared to VND 303,687.000 million a year ago. Operating income was VND 52,693.961 million compared to VND 51,343.564 million a year ago. Net income was VND 41,855.494 million compared to VND 41,114.210 million a year ago.